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T ubulointerstitial nephritis (TIN) is an inflamma-tory disorder in renal tubules and interstitium
without involvement of glomerular lesions. Causes of TIN
are diverse and include drug reactions, Sjögren syn-
drome, sarcoidosis, tubulointerstitial nephritis and uve-
itis (TINU) syndrome, and IgG4-related kidney disease,
although the causes remain unknown in many cases,
which are diagnosed as idiopathic TIN.1 Pathologically,
infiltrations of various inflammatory cells, including lym-
phocytes, plasma cells, and macrophages, are observed in
renal interstitium in TIN patients.2 Although infiltration
of IgG-positive plasma cells is a common finding in TIN
patients, Takahashi et al. recently reported TIN cases
with IgM-positive plasma cell accumulation within the
interstitium.3 The cases have characteristic findings of
high serum IgM levels, high prevalences of distal renal
tubular acidosis (d-RTA), Fanconi syndrome, positive
anti-mitochondrial antibodies (AMA), and primary
biliary cholangitis (PBC). These cases were termed
“IgM-positive plasma cell–tubulointerstitial nephritis”
(IgMPC-TIN).3 IgMPC-TIN may be the cause of some of
the idiopathic TIN cases with unknown etiology.
Although intermediate-dose glucocorticoid therapy is
highly effective in most cases of IgMPC-TIN,3 the long-
term prognosis of IgMPC-TIN is still uncertain. Here,
we describe 2 cases of IgMPC-TIN in patients who were
sensitive to initial glucocorticoid therapy but relapsed af-
ter early tapering of glucocorticoid.CASE PRESENTATION
Case 1
A 54-year-old Asian woman without significant past
medical history was referred to our department because
of renal dysfunction. Physical examination findings
were normal. Laboratory examination revealed a
elevated levels of serum creatinine (s-Cr, 1.2 mg/dl),
serum IgM (s-IgM, 716.6 mg/dl; normal range, 50–269
mg/dl) with normal levels of IgG and IgA, and hep-
atobiliary enzymes (alanine transaminase, 25 IU/l;
normal range, 7–23 IU/l; g-glutamyltransferase, 39 IU/l;
normal range, 9–32 IU/l). Urinalysis showed mild pro-
teinuria (0.5 g/gCr), renal glycosuria, and elevated level
of urinary b2-microglobin (u-b2MG, 65,010 mg/gCr and
32.7 mg/ml; normal range, 0–0.29 mg/ml) without he-
maturia. The patient had no symptoms of dry mouth or
dry eye, and anti–Sjögren syndrome (SS)–A and anti–
SS-B antibodies were negative, denying the possibility
of Sjögren syndrome. Further analysis revealed normal
anion gap metabolic acidosis (standard bicarbonate,
20.9 mmol/l; normal range, 22–26 mmol/l) with urinary
pH persistently >5.5, which suggested d-RTA.4 Her
first renal biopsy findings revealed severe infiltrations
of inflammatory cells, including lymphocytes and
plasma cells in the tubules and interstitium with
moderate interstitial fibrosis, tubular atrophy, and
tubulitis without glomerular abnormality
(Supplementary Figure S1; inflammatory cell infiltra-




Figure 1. The second renal biopsy and liver biopsy findings in case 1. (a) Light microscopy image with periodic acidSchiff stain, showing
massive inflammatory cell infiltration in renal tubulointerstitium. Original magnification 400. (b) Image of staining of IgG4, showing no infil-
tration by IgG4-positive plasma cells. Original magnification 100. (c) Image of dual staining of CD138 (brown) and IgM (pink), showing the
extent of IgM-CD138 dual-positive plasma cell infiltration. Original magnification 100. (d) Image of dual staining of CD138 (brown) and IgM
(pink), showing massive infiltration by IgM-CD138 dual-positive plasma cells in renal interstitium. Red arrows show representative IgM-CD138
dual-positive cells. Original magnification 400. (e) Light microscopy image with hematoxylin and eosin stain, showing nonsuppurative
destructive cholangitis in the liver. Original magnification 200. (f) Image of dual staining of CD138 (brown) and IgM (pink), showing massive
infiltration by IgM-CD138 dual-positive plasma cells in liver. Red arrows show representative IgM-CD138 dual-positive cells. Original
magnification 400.
N Matsuoka-Uchiyama et al.: Relapse of IgMPC-TIN NEPHROLOGY ROUNDS20%; tubulitis, mild). Immunofluorescence staining
was negative for immunoglobulins and comple-
ments. The patient was originally diagnosed with
idiopathic tubulointerstitial nephritis (TIN) with a
possibility of drug-induced TIN because she had
sometimes taken hyaluronic acid tablets, although
the result of the drug-induced lymphocyte stimu-
lation test for hyaluronic acid was negative. She was
treated with prednisolone (40 mg/d); her glycosuria
improved, and both u-b2MG and s-Cr levels gradu-
ally decreased (Supplementary Figure S2). Because of
side effects from prednisolone (fatigue and malaise),
prednisolone was tapered quickly and stopped after
3 months.Kidney International Reports (2020) 5, 1576–1580Seven months after the discontinuation of prednis-
olone, glycosuria reappeared, and the levels of s-Cr,
s-IgM, and u-b2MG gradually increased (Supplementary
Figure S2). Laboratory examination revealed mild pro-
teinuria (0.69 g/gCr), normal anion gap metabolic
acidosis, hypokalemia (3.8 mEq/l), hypophosphatemia
(3.1 mg/dl), hyperphosphaturia (percent tubular reab-
sorption of phosphate, 50.4%), and pan-aminoaciduria,
typical of Fanconi syndrome.5 Her second renal biopsy
was performed. Similar to the first biopsy result, there
were severe inflammatory cell infiltration of the tubules
and interstitium (Figure 1a–c; inflammatory cell infil-
tration, 60% including about 20% of plasma cells and
80% of lymphocytes; tubular atrophy and interstitial1577
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Figure 2. The second renal biopsy and liver biopsy findings in case 2. (a) Light microscopy image with periodic acid–Schiff stain, showing
massive inflammatory cell infiltration in renal tubulointerstitium. Original magnification 400. (b) Image of staining of IgG4, showing no infil-
tration by IgG4-positive plasma cells. Original magnification 100. (c) Image of dual staining of CD138 (brown) and IgM (pink), showing the
extent of IgM-CD138 dual-positive plasma cell infiltration. Original magnification 100. (d) Image of dual staining of IgM (pink) and CD138
(brown), showing massive infiltration by IgM-CD138 dual-positive plasma cells in renal interstitium. Red arrows show representative IgM-CD138
dual-positive cells. Original magnification 400.
NEPHROLOGY ROUNDS N Matsuoka-Uchiyama et al.: Relapse of IgMPC-TINfibrosis, 60%; tubulitis, severe; IgG4, negative). At this
time, we conducted dual staining of IgM and CD138, a
specific marker of plasma cells.6 There were IgM-CD138
double-positive cells in the tubulointersititium (21
infiltrating IgM-CD138 dual-positive plasma cells per
high-power field; Figure 1d), and we therefore rendered
a diagnosis of IgMPC-TIN. Because of the patient’s high
levels of hepatobiliary enzymes, we suspected PBC, and
further analysis was conducted. Anti-mitochondrial M2
antibody was positive, and liver biopsy was conducted,
which satisfied the PBC criteria (Figure 1e). Dual
staining of IgM and CD138 in the liver tissue also
revealed infiltrations of IgM-CD138 dual-positive
plasma cells (Figure 1f), suggesting the common path-
ophysiological conditions between the kidney and
liver. She was treated with prednisolone (45 mg/d) and
ursodeoxycholic acid. Her glycosuria resolved, and
both u-b2MG and s-IgM levels decreased
(Supplementary Figure S2).Case2
A 57-year-old Asian woman without significant past
medical history was referred to our department because
of impaired renal function and proteinuria (0.7 g/gCr).
Her s-Cr levels had increased from 1.2 mg/dl to 1.95 mg/
dl over 1 year. Her physical examination findings were1578normal. Laboratory examination revealed a high level of
s-IgM (516.6 mg/dl), a slight increase in hepatobiliary
enzymes (alkaline phosphatase, 353 IU/l; g-glutamyl-
transferase, 46 IU/l), and a high level of u-b2MG (81,701
mg/gCr) without hematuria. The patient had no symp-
toms of dry mouth or dry eye, and anti–SS-A and anti–
SS-B antibodies were negative, denying the possibility of
Sjögren syndrome. Renal biopsy findings revealed severe
infiltration of the tubules and interstitium by lympho-
cytes and plasma cells with moderate interstitial fibrosis
and tubular atrophy (Figure 2a–c; inflammatory cell
infiltration, 70% including about 30% of plasma cells
and 70% of lymphocytes; tubular atrophy and inter-
stitial fibrosis, 50%; tubulitis, moderate; IgG4, nega-
tive). No glomerular abnormality was observed.
Immunofluorescence staining was negative for immu-
noglobulins and complements. She had sometimes taken
loxoprofen, acetaminophen, and zolpidem. Thus, we
conducted a drug-induced lymphocyte stimulation test
for these medications, and the acetaminophen test result
was positive. Hence, she was diagnosed drug-induced
TIN by acetaminophen. She was then treated with
prednisolone (50 mg/d) and stopped taking acetamino-
phen. Her glycosuria disappeared immediately, and
both u-b2MG and s-Cr levels gradually decreased
(Supplementary Figure S3). Prednisolone treatment was
tapered to 3 mg/d within 6 months.Kidney International Reports (2020) 5, 1576–1580
Table 1. Pre- and post-treatment laboratory values
Laboratory data Pretreatment Post-treatment P value
s-Cr (mg/dl) 1.42  0.45 1.31  0.40 0.062a
eGFR (ml/min per 1.73 m2) 35.4  10.9 38.1  13.8 0.225a
U-P (g/gCr) 1.51  1.76 0.58  0.56 <0.001a
s-IgM (mg/dl) 837  385 401  259 <0.001a
u-b2MG(mg/l) 48,922  29,880 26,801  29,994 0.004a
Glucosuria þ/– 16/1 8/8 0.007b
eGFR, estimated glomerular filtration rate; s-Cr, serum creatinine; s-IgM, serum IgM;
U-P, urinary protein; U-b2MG, urinary b2-microglobin.
aStatistical calculations using Wilcoxon signed rank test were performed using JMP
version 14.0 (SAS Institute, Cary, NC).
bStatistical calculations using Fisher exact test were performed using JMP version 14.0
N Matsuoka-Uchiyama et al.: Relapse of IgMPC-TIN NEPHROLOGY ROUNDSThree months after the prednisolone tapering to 3
mg/d, glycosuria reappeared, and levels of s-Cr, s-IgM,
and u-b2MG increased (Supplementary Figure S3).
IgM-CD138 dual staining in tissue from the original
kidney biopsy was performed. There were IgM-CD138
double-positive cells in the tubulointersititium
(Figure 2d; 84 infiltrating IgM-CD138 dual-positive
plasma cells per high-power field), which led to the
diagnosis of IgMPC-TIN. Prednisolone dose increased
(20 mg/d), and the levels of s-Cr, s-IgM, and u-b2MG
were decreased (Supplementary Figure S3).(SAS Institute).
Data of the first treatment and the second treatment after the recurrence in our cases
are included.
Table 2. Teaching points
1. TIN with IgM-positive plasma cells may be the cause of some of the idiopathic TIN
cases with unknown etiology.
2. Although IgM-PC-TIN cases are steroid sensitive in most cases, we need to be aware
of possible relapse even after remission with initial glucocorticoid therapy.
3. Monitoring levels of u-bMG, s-IgM, s-Cr, and glycosuria may facilitate detection of
relapse.
TIN, tubulointerstitial nephritis.DISCUSSION
This is the first report of IgMPC-TIN cases that relapsed
after prednisolone treatment. Our 2 cases had been
initially diagnosed with idiopathic or drug-induced
TIN at the first examination and were subsequently
diagnosed with IgMPC-TIN with a second analysis af-
ter the relapse of TIN. Because IgMPC-TIN may be
associated with involvement of other organs, including
the liver and salivary glands, appropriate diagnosis of
IgMPC-TIN is important for proper treatment and
monitoring. In addition, it is reported that ursodeox-
ycholic acid may reduce s-IgM levels in PBC7,8; thus it
may be a useful option for reducing infiltration by
IgM-CD138–positive plasma cells in IgMPC-TIN cases,
thereby preventing the possible relapse of TIN. In
addition to the high levels of s-IgM, prominent plasma
cell infiltration in renal tubulointerstitial areas is
another important characteristic of IgMPC-TIN.
Although prominent plasma cell infiltration is known
to be observed in other causes of TIN, including IgG4-
related kidney disease, Sjögren syndrome,S1 and some
drug-induced TIN, we also need to consider IgMPC-
TIN as one of the differential diagnoses in cases of
plasma cell infiltrations in TIN cases. Taken together,
nephrologists need to be aware of IgMPC-TIN cases and
might need to re-examine the past cases of TIN, espe-
cially when the patients had high s-IgM levels and/or
prominent plasma cell infiltration.
For the diagnosis of IgMPC-TIN, the infiltration of
IgM-positive plasma cells in the tubulointerstitium by
IgM-CD138 dual staining is required.3 Mizoguchi et al.
recently reported cases of the concurrence of PBC and
TIN with positive IgM staining in renal tissue. They
summarized 16 cases, indicating the possibility of
IgMPC-TIN.9 However, they did not perform IgM-
CD138 dual staining, and therefore were unable to
indicate IgM-positive plasma cell infiltration and make
the diagnosis of IgMPC-TIN. Interestingly, it is diffi-
cult to observe IgM deposition in tubulointersititium
by conventional immunofluorescence staining; instead,
this requires immunohistochemical staining ofKidney International Reports (2020) 5, 1576–1580formalin-fixed, paraffin-embedded renal biopsy speci-
mens after antigen retrieval. It had been reported that
some of the IgMPC-TIN cases are slightly positive for
IgM on the tubular basement membrane by immu-
nofluorescence staining, but this is often too slight to
be recognized. It is possible that the enzyme treatment
after heat treatment, which is needed for IgM-CD138
dual staining, makes it easier to react to the anti-
bodies by unmasking IgM epitopes.S2
In our first case, the liver specimen, in addition to the
kidney, had infiltrating IgM-CD138 dual-positive
plasma cells, suggesting that IgMPC-TIN might not be
only a kidney disease but a systemic disease similar to
IgG4-related kidney disease. This hypothesis might
explain why IgMPC-TIN patients have several specific
symptoms, including PBC, d-RTA, Fanconi syndrome,
and Sjögren syndrome. In fact, there are a number of
reported cases with co-occurrence of TIN and Sjögren
syndrome and/or PBC. However, it is unknownwhether
all these reported cases might fulfill IgMPC-TIN criteria
because of the lack of IgM-CD138 dual staining. Further
accumulations of IgMPC-TIN cases and systemic ana-
lyses are required to define the clinical features and to
establish the diagnostic criteria.
According to the previous report, patients with
IgMPC-TIN are more likely to be sensitive to gluco-
corticoid.3 However, data on long-term prognosis are
still lacking. Despite the initial sensitivity to gluco-
corticoid in our cases, there were relapses after rapid
tapering of glucocorticoid in both cases, indicating that
IgMPC-TIN cases might be relapsed. Although further1579
NEPHROLOGY ROUNDS N Matsuoka-Uchiyama et al.: Relapse of IgMPC-TINanalysis is required to determine whether we need to
taper the glucocorticoid more slowly, continue gluco-
corticoid treatment in the maintenance dosage, or add
another immunosuppressant to the treatment in
IgMPC-TIN cases, careful monitoring seems necessary
even after the remission. Which parameters can be
good markers under the treatment? We compared pre-
and post-treatment values of the 13 patients in the
original report3 and our 2 patients (Supplementary
Table S1 and Table 1). Levels of urinary protein,
s-IgM, and u-b2MG in the post-treatment group were
significantly lower compared to those in the pretreat-
ment group, and glycosuria significantly improved af-
ter the treatment. On the other hand, s-Cr and
estimated glomerular filtration rate were not signifi-
cantly improved (Table 1). In our cases, high levels of
s-Cr, s-IgM, and u-b2MG as well as the glycosuria had
been improved after the initial treatment, and these
parameters worsened again at the relapse. Taken
together, we conclude that levels of s-IgM, u-b2MG,
and s-Cr as well as glycosuria can be useful markers in
the treatment of IgMPC-TIN cases.
In conclusion, we have presented 2 cases of IgMPC-
TIN that were sensitive to the initial glucocorticoid
treatment but that relapsed after tapering of gluco-
corticoid. Although most cases of IgMPC-TIN are sen-
sitive to glucocorticoid, some of them may relapse.
Therefore, we propose to monitor levels of s-IgM, u-
b2MG and s-Cr as well as glycosuria in the treatment to
find or to avoid the recurrence of IgMPC-TIN (Table 2).
DISCLOSURE
All the authors declared no competing interests.
SUPPLEMENTARY MATERIAL
Supplementary File (PDF)
Figure S1. The first renal biopsy finding in case 1. (A) Light
microscopy image of kidney with periodic acidSchiff1580stain, showing intact glomeruli. (B) Light microscopy im-
age of kidney with periodic acidSchiff stain, showing
massive inflammatory infiltration in tubulointerstitium.
Figure S2. Clinical course in case 1.
Figure S3. Clinical course in case 2.
Table S1. Clinical and immunohistologic data of IgMPC-
TIN at the time of renal biopsy.
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